Annual EBIT
-$402.27 M
-$178.78 M-80.00%
December 31, 2023
Summary
- As of February 26, 2025, PCVX annual earnings before interest & taxes is -$402.27 million, with the most recent change of -$178.78 million (-80.00%) on December 31, 2023.
- During the last 3 years, PCVX annual EBIT has fallen by -$313.06 million (-350.92%).
- PCVX annual EBIT is now -1267.79% below its all-time high of -$29.41 million, reached on December 31, 2018.
Performance
PCVX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$139.63 M
+$12.96 M+8.49%
September 30, 2024
Summary
- As of February 26, 2025, PCVX quarterly earnings before interest & taxes is -$139.63 million, with the most recent change of +$12.96 million (+8.49%) on September 30, 2024.
- Over the past year, PCVX quarterly EBIT has stayed the same.
- PCVX quarterly EBIT is now -1210.61% below its all-time high of -$10.65 million, reached on June 30, 2019.
Performance
PCVX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$542.23 M
-$28.25 M-5.50%
September 30, 2024
Summary
- As of February 26, 2025, PCVX TTM earnings before interest & taxes is -$542.23 million, with the most recent change of -$28.25 million (-5.50%) on September 30, 2024.
- Over the past year, PCVX TTM EBIT has stayed the same.
- PCVX TTM EBIT is now -3870.02% below its all-time high of -$13.66 million, reached on March 31, 2019.
Performance
PCVX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
PCVX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -80.0% | 0.0% | 0.0% |
| 3 y3 years | -350.9% | -424.6% | -475.8% |
| 5 y5 years | -1267.8% | -1134.8% | -979.4% |
PCVX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -302.0% | at low | -388.9% | +8.5% | -431.6% | at low |
| 5 y | 5-year | -700.8% | at low | -855.5% | +8.5% | -979.4% | at low |
| alltime | all time | -1267.8% | at low | -1210.6% | +8.5% | -3870.0% | at low |
Vaxcyte EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$139.63 M(-8.5%) | -$542.23 M(+5.5%) |
| Jun 2024 | - | -$152.59 M(+33.4%) | -$513.98 M(+15.2%) |
| Mar 2024 | - | -$114.35 M(-15.7%) | -$446.07 M(+10.9%) |
| Dec 2023 | -$402.27 M(+80.0%) | -$135.66 M(+21.8%) | -$402.27 M(+16.7%) |
| Sep 2023 | - | -$111.39 M(+31.5%) | -$344.66 M(+18.4%) |
| Jun 2023 | - | -$84.68 M(+20.1%) | -$291.19 M(+14.2%) |
| Mar 2023 | - | -$70.54 M(-9.6%) | -$255.03 M(+14.1%) |
| Dec 2022 | -$223.48 M(+123.3%) | -$78.05 M(+34.8%) | -$223.56 M(+28.4%) |
| Sep 2022 | - | -$57.92 M(+19.3%) | -$174.07 M(+21.9%) |
| Jun 2022 | - | -$48.53 M(+24.2%) | -$142.77 M(+21.1%) |
| Mar 2022 | - | -$39.06 M(+36.8%) | -$117.91 M(+15.6%) |
| Dec 2021 | -$100.07 M | -$28.56 M(+7.3%) | -$101.99 M(+8.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$26.61 M(+12.4%) | -$94.17 M(+6.3%) |
| Jun 2021 | - | -$23.67 M(+2.3%) | -$88.57 M(+3.9%) |
| Mar 2021 | - | -$23.14 M(+11.6%) | -$85.22 M(-4.5%) |
| Dec 2020 | -$89.21 M(+77.6%) | -$20.74 M(-1.3%) | -$89.21 M(+7.4%) |
| Sep 2020 | - | -$21.02 M(+3.4%) | -$83.09 M(+13.2%) |
| Jun 2020 | - | -$20.32 M(-25.1%) | -$73.38 M(+15.2%) |
| Mar 2020 | - | -$27.14 M(+85.7%) | -$63.71 M(+26.8%) |
| Dec 2019 | -$50.23 M(+70.8%) | -$14.61 M(+29.2%) | -$50.23 M(+41.0%) |
| Sep 2019 | - | -$11.31 M(+6.1%) | -$35.62 M(+46.5%) |
| Jun 2019 | - | -$10.65 M(-22.0%) | -$24.31 M(+78.0%) |
| Mar 2019 | - | -$13.66 M | -$13.66 M |
| Dec 2018 | -$29.41 M | - | - |
FAQ
- What is Vaxcyte annual earnings before interest & taxes?
- What is the all time high annual EBIT for Vaxcyte?
- What is Vaxcyte annual EBIT year-on-year change?
- What is Vaxcyte quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Vaxcyte?
- What is Vaxcyte quarterly EBIT year-on-year change?
- What is Vaxcyte TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Vaxcyte?
- What is Vaxcyte TTM EBIT year-on-year change?
What is Vaxcyte annual earnings before interest & taxes?
The current annual EBIT of PCVX is -$402.27 M
What is the all time high annual EBIT for Vaxcyte?
Vaxcyte all-time high annual earnings before interest & taxes is -$29.41 M
What is Vaxcyte annual EBIT year-on-year change?
Over the past year, PCVX annual earnings before interest & taxes has changed by -$178.78 M (-80.00%)
What is Vaxcyte quarterly earnings before interest & taxes?
The current quarterly EBIT of PCVX is -$139.63 M
What is the all time high quarterly EBIT for Vaxcyte?
Vaxcyte all-time high quarterly earnings before interest & taxes is -$10.65 M
What is Vaxcyte quarterly EBIT year-on-year change?
Over the past year, PCVX quarterly earnings before interest & taxes has changed by $0.00 (0.00%)
What is Vaxcyte TTM earnings before interest & taxes?
The current TTM EBIT of PCVX is -$542.23 M
What is the all time high TTM EBIT for Vaxcyte?
Vaxcyte all-time high TTM earnings before interest & taxes is -$13.66 M
What is Vaxcyte TTM EBIT year-on-year change?
Over the past year, PCVX TTM earnings before interest & taxes has changed by $0.00 (0.00%)